Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
about
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cellsMicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for TreatmentMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerLinking epithelial-to-mesenchymal-transition and epigenetic modificationsMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerNon-coding RNAs as theranostics in human cancersEpigenetics of lung cancerDNA methylation and microRNA dysregulation in cancerThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identitymicroRNA-200b as a Switch for Inducible Adult AngiogenesisThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancermiR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinomamiRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25miR-200b as a prognostic factor in breast cancer targets multiple members of RAB familyTherapeutic use of microRNAs in lung cancerChemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathwayMiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathwayOverexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-AMicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabRegulation of miR-200c by nuclear receptors PPARĪ±, LRH-1 and SHPReciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.MiR-200c Inhibits the Tumor Progression of Glioma via Targeting MoesinThe potential clinical applications and prospects of microRNAs in lung cancerDynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesisTranscription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.MicroRNAs As Biomarkers For Clinical Features Of Lung CancerThe epigenetics of epithelial-mesenchymal plasticity in cancer.Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathwaysDysfunctions associated with methylation, microRNA expression and gene expression in lung cancerEpigenetic alteration and microRNA dysregulation in cancerReversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.Regulation of cancer metastasis by cell-free miRNAs.Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Inferring the perturbed microRNA regulatory networks in cancer using hierarchical gene co-expression signatures.Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatinPromoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.MicroRNA (miRNA) in cancerTherapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
P2860
Q23909716-D23D2178-980C-49F4-B443-5A8490549D4FQ26752548-EF1AAEE7-81A4-4439-96DC-9F86EF36CDDCQ26775086-7C424099-0263-4274-80A8-FE59E79480A1Q26824575-848CFDDB-C16B-4B98-8F0F-E3DD58F14C3EQ26849525-ABF3CD3C-BC62-4B8D-86A6-16787E53D962Q26851250-B44E3547-35B8-4D83-BA4A-F3CD1631C316Q26996766-2335AE79-0EC7-4F2B-A9A6-0BBD27F70447Q26998741-8CA04A54-B31A-49DA-B344-ED01C791E257Q27010233-F6822438-8DE2-4F0E-8B32-543109ACE21CQ28080485-5EE3CE44-A65B-4FD8-80B2-E8B7EF91BB53Q28387891-982F6D79-A12F-4201-8221-4AB890312AC2Q28389722-8E979A56-B9F0-4449-B02A-1AACC5C801DAQ28390685-F68B65E2-4CC8-448B-9842-CB6590836358Q28394618-DFB9DEB6-A22A-4C47-B196-DECA2D29145AQ28395179-65E8A04F-82B1-4009-9E47-A45EF8EE7DCCQ28480873-7D014388-04D4-4459-B46E-3CE6B6942D13Q28534731-20DBAE4B-E37B-449C-A8E2-DEEAAB549892Q28828213-7C842612-BEC0-47CB-8E05-5D6F5A83F945Q30008813-3D2BD650-8239-4082-A51A-3B043DF2B18EQ30415894-C2BDECAD-4CA7-4D18-85B5-15713318A1D8Q30423418-53847F81-C10F-4989-B36F-51F9CBEED024Q33599015-1DCC58C8-1751-465A-AB2C-7ED92E5BC7A8Q33703121-9ADF70E4-C3FD-4C2F-AEA7-ED6978521795Q33734765-B4150D46-039F-47E0-A065-F56F8F7BA33AQ34004676-B2848500-DCD1-4169-B6AF-1DC32C9C89BAQ34029138-5F0C5C74-8668-44DA-AB8E-BEDB7B20765BQ34158964-904C21A3-CC5E-4420-9856-179E8375F6A1Q34310378-C504C0D1-8144-4653-A1AC-75B092A9E6FBQ34326145-6E8410B8-52AA-4124-9ABC-F084F913ED9CQ34389624-6A82B2A8-4DE3-4B12-8BC9-2B4AFA63A965Q34392645-F600A812-4854-4FCE-969C-14CE31F14D79Q34824379-DD332188-C1E0-43E2-B534-92791FDAC625Q35034340-051C1DE9-EDB9-4FD7-BF16-1E15BDBE7072Q35039281-0FEFA744-32EF-4B87-A9A3-8223F29778C1Q35053844-AFEF66FA-9685-456F-BE12-E45CC7F0867BQ35105401-75BFE4C2-ADB6-42D7-B7F5-E2E028F39844Q35107566-8D81F49A-72BF-4277-B234-E483FD8AC62CQ35128520-B7683947-472C-4017-AD88-D7C6AA1964C0Q35583538-DA683D0E-4D1E-4B96-809D-977F6EFCAE6FQ35618817-95ACCB9A-573C-4951-A190-AE2D61AC361E
P2860
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010幓ć®č«ę
@ja
2010幓č«ę
@yue
2010幓č«ę
@zh-hant
2010幓č«ę
@zh-hk
2010幓č«ę
@zh-mo
2010幓č«ę
@zh-tw
2010幓č®ŗę
@wuu
2010幓č®ŗę
@zh
2010幓č®ŗę
@zh-cn
name
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@en
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@nl
type
label
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@en
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@nl
prefLabel
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@en
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@nl
P2093
P1476
Loss of miR-200c expression in ...... in non-small cell lung cancer.
@en
P2093
Giorgio V Scagliotti
Giridhar Mudduluru
Heike Allgayer
Mauro Papotti
Paolo Ceppi
Regalla Kumarswamy
P304
P356
10.1158/1541-7786.MCR-10-0052
P577
2010-08-09T00:00:00Z